Vote Scores

Home / Companies / Shanghai RAAS Blood Products Co., Ltd. / 11 Dec 2023

Meeting · year to 30 June 202431 filers reporting

Shanghai RAAS Blood Products Co., Ltd.: meeting of 11 Dec 2023

Votes reported on Form N-PX, item by item

31 Form N-PX filers reported votes at the Shanghai RAAS Blood Products Co., Ltd. meeting of 11 Dec 2023. Their records fall into 1 item below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

125 vote records from 31 filers. 0 of the 31 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management31 filers100.0% for0.0% against0.0% against management85,638,576 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Shanghai RAAS Blood Products Co., Ltd. meeting?

31 Form N-PX filers reported votes at the meeting of 11 Dec 2023. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Shanghai RAAS Blood Products Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Shanghai RAAS Blood Products Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Shanghai RAAS Blood Products Co., Ltd. with a meeting date within three days of 11 Dec 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.